<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19-biomolecules-09-00138" class="ref">
 <label class="label">19.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Guilherme</surname>
    <given-names class="given-names">V.A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ribeiro</surname>
    <given-names class="given-names">L.N.M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Tofoli</surname>
    <given-names class="given-names">G.R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Franz-Montan</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">de Paula</surname>
    <given-names class="given-names">E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">de Jesus</surname>
    <given-names class="given-names">M.B.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Current challenges and future of lipid nanoparticles formulations for topical drug application to oral mucosa, skin, and eye</article-title>
  <source class="source">Curr. Pharm. Des.</source>
  <year class="year">2017</year>
  <volume class="volume">23</volume>
  <fpage class="fpage">6659</fpage>
  <lpage class="lpage">6675</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.2174/1381612823666171122103849</pub-id>
 </element-citation>
</ref>
